How logically impossible patents block biosimilars
Nat Biotechnol
.
2019 Aug;37(8):862-863.
doi: 10.1038/s41587-019-0196-x.
Authors
W Nicholson Price 2nd
1
2
,
Arti K Rai
3
Affiliations
1
University of Michigan Law School, Ann Arbor, MI, USA. wnp@umich.edu.
2
Centre for Advanced Studies in Biomedical Innovation Law, Copenhagen, Denmark. wnp@umich.edu.
3
Duke University Law School and Duke-Margolis Center for Health Policy, Durham, NC, USA.
PMID:
31375793
DOI:
10.1038/s41587-019-0196-x
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Biosimilar Pharmaceuticals / chemistry*
Biosimilar Pharmaceuticals / economics*
Commerce
Humans
Patents as Topic*
Substances
Biosimilar Pharmaceuticals